Mitbbs划时代历史性大事件# Living
N*K
1 楼
看点在此
It is important to note that the success rates for targeted and investigator
-initiated RPG awards are primarily the same,
=============================================================
Rock Talk
Helping connect you with the NIH perspective
2014 By the Numbers
Posted on December 31, 2014 by Sally Rockey
Application and award summary data for fiscal year 2014 are now available in
the NIH Data Book. These data are of particular interest for all of us this
year, considering the historic low of the success rate last year, and the
reduction of NIH’s budget in fiscal year 2013, due to sequestration. For
this reason, in the table below, we include both FY 2013 and FY 2012 data
for comparison purposes.
We received 51,073 competing RPG applications at NIH in fiscal year 2014, an
increase compared to last year, but still below the highest number of
applications received by NIH in a fiscal year (51,313 applications in FY
2012). We’ll continue to monitor this closely, to see if there is a true
downward trend in incoming RPG applications, and to observe the effects of
the new resubmission policy announced last April.
Looking at data across both competing and non-competing awards, the average
size of RPGs increased to a historical high ($472,827), but in constant
dollars (normalized to 1999 value of a dollar as per the biomedical research
price index) it is similar to 2012 ($293,463 in FY14 versus $293,141 in
FY12). In FY14, the average size of R01-equivalent awards was the highest in
history ($427,083), but constant dollars it is the smallest award size
since 1999 ($265,072) except for during the FY13 sequestration ($254,719).
The large increase in the average size of RPG awards (up 7% compared to FY13
, and up 4% compared to FY12) can be explained by the number of large
collaborative infectious disease research projects that were issued. Many of
these particular projects were up for competing renewals. Also, the average
size of R01s, the largest component of the RPG pool, went up 6% compared to
2013, and up 3% compared to 2012.
Interestingly, there was a large increase in the percentage of RPG funding
that went towards targeted research programs. Remember that in 2014 NIH
launched a large number of initiatives in cancer, diabetes, Alzheimer’s,
emerging infectious diseases, and the BRAIN, BD2K, and BUILD projects. It is
important to note that the success rates for targeted and investigator-
initiated RPG awards are primarily the same, with investigator-initiated
success rates slightly higher than targeted research success rates, showing
that these targeted programs are as competitive as our investigator
initiated programs. (The percentage of new R01-equivalent grant awards and
funding to targeted research remained stable compared to recent history.)
I’ve included a highlight of some additional numbers below, and provided
the last fiscal year as well the prior fiscal year, since the 2013
sequestration was an unusual circumstance. We’ll take a closer look at more
of this data later in 2015. Have fun data diving!
2012 2013 2014
Number of research project grant (RPG) applications: 51,313 49, 581
51,073
Number of RPG awards: 9,032 8,310 9,241
Success rate of RPGs applications: 17.6% 16.8% 18.1%
Average size of RPGs: $454,588 $441,404 $472,827
Average size of RPG awards in constant (1999) dollars: $293,141 $279
,291 $293,463
Total amount of NIH funding that went to RPGs: $15,923,746,065 $14,
917,675,859 $15,635,912,476
Number of R01-equivalent grant applications: 29,627 28,044 27,
502
Number of R01-equivalent awards: 5,437 4,902 5,163
Success rates for R01-equivalent applications: 18.4% 17.5% 18.8%
Average size of R01-equivalent awards: $415,445 $402,569 $427,
083
Average size of R01-equivalent awards in constant (1999) dollars: $267,
900 $254,719 $265,072
Total amount of NIH funding that went to R01-equivalents: $10,898,788,
608 $10,075,486,256 $10,238,888,890
- See more at: file:///C:/Users/Liang/Desktop/grant/2014%20By%20the%
20Numbers%20_%20NIH%20Extramural%20Nexus.html#sthash.5HEDCLij.dpuf
It is important to note that the success rates for targeted and investigator
-initiated RPG awards are primarily the same,
=============================================================
Rock Talk
Helping connect you with the NIH perspective
2014 By the Numbers
Posted on December 31, 2014 by Sally Rockey
Application and award summary data for fiscal year 2014 are now available in
the NIH Data Book. These data are of particular interest for all of us this
year, considering the historic low of the success rate last year, and the
reduction of NIH’s budget in fiscal year 2013, due to sequestration. For
this reason, in the table below, we include both FY 2013 and FY 2012 data
for comparison purposes.
We received 51,073 competing RPG applications at NIH in fiscal year 2014, an
increase compared to last year, but still below the highest number of
applications received by NIH in a fiscal year (51,313 applications in FY
2012). We’ll continue to monitor this closely, to see if there is a true
downward trend in incoming RPG applications, and to observe the effects of
the new resubmission policy announced last April.
Looking at data across both competing and non-competing awards, the average
size of RPGs increased to a historical high ($472,827), but in constant
dollars (normalized to 1999 value of a dollar as per the biomedical research
price index) it is similar to 2012 ($293,463 in FY14 versus $293,141 in
FY12). In FY14, the average size of R01-equivalent awards was the highest in
history ($427,083), but constant dollars it is the smallest award size
since 1999 ($265,072) except for during the FY13 sequestration ($254,719).
The large increase in the average size of RPG awards (up 7% compared to FY13
, and up 4% compared to FY12) can be explained by the number of large
collaborative infectious disease research projects that were issued. Many of
these particular projects were up for competing renewals. Also, the average
size of R01s, the largest component of the RPG pool, went up 6% compared to
2013, and up 3% compared to 2012.
Interestingly, there was a large increase in the percentage of RPG funding
that went towards targeted research programs. Remember that in 2014 NIH
launched a large number of initiatives in cancer, diabetes, Alzheimer’s,
emerging infectious diseases, and the BRAIN, BD2K, and BUILD projects. It is
important to note that the success rates for targeted and investigator-
initiated RPG awards are primarily the same, with investigator-initiated
success rates slightly higher than targeted research success rates, showing
that these targeted programs are as competitive as our investigator
initiated programs. (The percentage of new R01-equivalent grant awards and
funding to targeted research remained stable compared to recent history.)
I’ve included a highlight of some additional numbers below, and provided
the last fiscal year as well the prior fiscal year, since the 2013
sequestration was an unusual circumstance. We’ll take a closer look at more
of this data later in 2015. Have fun data diving!
2012 2013 2014
Number of research project grant (RPG) applications: 51,313 49, 581
51,073
Number of RPG awards: 9,032 8,310 9,241
Success rate of RPGs applications: 17.6% 16.8% 18.1%
Average size of RPGs: $454,588 $441,404 $472,827
Average size of RPG awards in constant (1999) dollars: $293,141 $279
,291 $293,463
Total amount of NIH funding that went to RPGs: $15,923,746,065 $14,
917,675,859 $15,635,912,476
Number of R01-equivalent grant applications: 29,627 28,044 27,
502
Number of R01-equivalent awards: 5,437 4,902 5,163
Success rates for R01-equivalent applications: 18.4% 17.5% 18.8%
Average size of R01-equivalent awards: $415,445 $402,569 $427,
083
Average size of R01-equivalent awards in constant (1999) dollars: $267,
900 $254,719 $265,072
Total amount of NIH funding that went to R01-equivalents: $10,898,788,
608 $10,075,486,256 $10,238,888,890
- See more at: file:///C:/Users/Liang/Desktop/grant/2014%20By%20the%
20Numbers%20_%20NIH%20Extramural%20Nexus.html#sthash.5HEDCLij.dpuf